Skip to content

Oleandomycin Phosphate Susceptibility Powder

by Pfizer Inc. PMA

Active United States

PMA N50062

Overview

The Oleandomycin Phosphate Susceptibility Powder is a Susceptibility Test Powder, Antimicrobial (per FDA nomenclature), designed for use in microbiological testing to determine bacterial susceptibility to oleandomycin phosphate. This powder is intended for in vitro diagnostic use, enabling laboratories to assess whether bacterial isolates are resistant or susceptible to the antibiotic, aiding in appropriate antimicrobial therapy selection.

This powder is supplied as a sterile, single-use diagnostic reagent for microbiological laboratories. It is classified under FDA device class II (866.1640) and is regulated under the FDA_PMA authorization (PMA Number: N50062). Storage conditions and handling must comply with standard microbiological practices to maintain sterility and accuracy of susceptibility testing results.

AI-generated from registry data, 18 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 27 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPRL NumberN50062 Date24 Nov 1969DecidedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA PMA Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

PMA

Generic Name
Susceptibility test powders, antimicrobial
FDA applicant
Pfizer, Inc.
PMA Number
FDA Product Code
JTT
Device Class
Class II
Regulation
21 CFR Part 866.1640
Advisory Committee
Microbiology
FDA Decision
APRL

Other devices from Pfizer Inc.

See all devices from Pfizer Inc. →

Questions

  • What is the Oleandomycin Phosphate Susceptibility Powder used for in a clinical setting?

    This powder is specifically designed for in vitro diagnostic use in microbiological laboratories. It helps determine whether bacterial isolates are resistant or susceptible to oleandomycin phosphate, which assists clinicians in selecting the most appropriate antibiotic therapy for patients.

  • Is the Oleandomycin Phosphate Susceptibility Powder intended for single-use or repeated use?

    The powder is supplied as a sterile, single-use diagnostic reagent. This ensures accuracy and reliability in susceptibility testing, as reuse could compromise sterility and test integrity.

  • How should the Oleandomycin Phosphate Susceptibility Powder be stored to maintain its effectiveness?

    Storage must follow standard microbiological practices to preserve sterility and ensure accurate susceptibility testing results. While exact conditions aren’t detailed here, adherence to general laboratory protocols for antimicrobial susceptibility powders is recommended.

  • What regulatory pathway does the Oleandomycin Phosphate Susceptibility Powder follow?

    The product is regulated under the FDA’s Premarket Approval (PMA) pathway, with the assigned PMA number N50062. It falls under FDA device class II (product code JTT), indicating it requires a higher level of scrutiny than class I but not as stringent as class III.

  • What type of laboratory would typically use the Oleandomycin Phosphate Susceptibility Powder?

    This powder is intended for microbiology laboratories that perform antimicrobial susceptibility testing. It aids in identifying bacterial resistance patterns to oleandomycin phosphate, which is critical for infectious disease management and antibiotic stewardship programs.